# ELEVANCE HEALTH, INC. (ELV) FY2025 Annual P&L / Income Statement

- Company: ELEVANCE HEALTH, INC. (ELV)
- Period: 2025-01-01 to 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-06, accession number 0001156039-26-000013
- Page: https://plicit.ai/financials/elv/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/elv-fy2025-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service (4 categories)

Income statement for 2025-01-01 through 2025-12-31. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 199,125,000,000 US dollars
- **Total expenses**: 192,415,000,000 US dollars
- **Operating profit (calculated)**: 6,710,000,000 US dollars
- **Other income (expense), net (calculated)**: 0 US dollars
- **Income before income tax expense**: 6,710,000,000 US dollars
- **Income tax expense**: 1,049,000,000 US dollars
- **Net income**: 5,661,000,000 US dollars
- **Net investment income**: 2,194,000,000 US dollars
- **Total operating revenue**: 197,584,000,000 US dollars
- **Gain on sale of business**: 0 US dollars
- **Benefit expense**: 148,223,000,000 US dollars
- **Cost of products sold**: 21,178,000,000 US dollars
- **Operating expense**: 20,984,000,000 US dollars
- **Interest expense**: 1,402,000,000 US dollars
- **Amortization of other intangible assets**: 628,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 199,778,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Net losses on financial instruments**: negative 653,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to ELEVANCE HEALTH, INC.: $5.66 B; to noncontrolling interests: −$1.00 M.
